Clinical Trial Update: Genetic and Dietary Predictors of Anti-platelet Response [Phase 4]

View source ↗

Summary

Phase 4 trial investigating genetic and dietary predictors of anti-platelet response; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platelet Function Disorders

Snippet

Sponsor: University of Washington | Conditions: Platelet Function | Phase 4 | Status: TERMINATED